NMD3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.498200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.090400E-01
Normal-vs-Stage2
3.878400E-01
Normal-vs-Stage3
8.388400E-01
Normal-vs-Stage4
8.406300E-02
Stage1-vs-Stage2
5.223200E-01
Stage1-vs-Stage3
3.009200E-01
Stage1-vs-Stage4
3.609800E-02
Stage2-vs-Stage3
2.475200E-01
Stage2-vs-Stage4
9.252000E-02
Stage3-vs-Stage4
3.482000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.458000E-01
Normal-vs-AfricanAmerican
6.136400E-01
Normal-vs-Asian
8.496200E-01
Caucasian-vs-AfricanAmerican
7.672400E-01
Caucasian-vs-Asian
2.719000E-01
AfricanAmerican-vs-Asian
6.354400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.645400E-01
Normal-vs-Female
4.348400E-01
Male-vs-Female
8.470200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.870000E-01
Normal-vs-Age(41-60Yrs)
2.283400E-01
Normal-vs-Age(61-80Yrs)
5.727400E-01
Normal-vs-Age(81-100Yrs)
6.503400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.316400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.807200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.542000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.171840E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.704200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.033400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.390200E-01
Normal-vs-Daily Drinker
8.604400E-01
Normal-vs-Weekly Drinker
6.992200E-01
Normal-vs-Occasional Drinker
2.713000E-01
Normal-vs-Social Drinker
4.145400E-01
Non Drinker-vs-Daily Drinker
3.610600E-01
Non Drinker-vs-Weekly Drinker
6.840000E-01
Non Drinker-vs-Occasional Drinker
9.869700E-02
Non Drinker-vs-Social Drinker
5.857200E-01
Daily Drinker-vs-Weekly Drinker
7.083600E-01
Daily Drinker-vs-Occasional Drinker
3.216000E-02
Daily Drinker-vs-Social Drinker
2.129600E-01
Weekly Drinker-vs-Occasional Drinker
1.134570E-01
Weekly Drinker-vs-Social Drinker
4.245400E-01
Occasional Drinker-vs-Social Drinker
3.595000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.285620E-01
Normal-vs-Grade 2
9.298600E-03
Normal-vs-Grade 3
1.654260E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.191300E-04
Grade 1-vs-Grade 3
9.69360000000474E-05
Grade 1-vs-Grade 4
1.285620E-01
Grade 2-vs-Grade 3
1.262790E-01
Grade 2-vs-Grade 4
9.298600E-03
Grade 3-vs-Grade 4
1.654260E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.812600E-01
Normal-vs-NonDiabetic
5.209000E-01
Diabetic-vs-NonDiabetic
7.883200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.222400E-01
Normal-vs-NoPancreatitis
5.116400E-01
Pancreatitis-vs-NoPancreatitis
8.689600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.794800E-01
Normal-vs-N1
3.838600E-01
N0-vs-N1
2.228200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.711000E-01
Normal-vs-TP53-NonMutant
5.708000E-01
TP53-Mutant-vs-TP53-NonMutant
1.195250E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
